Compare DUOL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOL | MEDP |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 13.4B |
| IPO Year | 2021 | 2016 |
| Metric | DUOL | MEDP |
|---|---|---|
| Price | $198.73 | $543.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 12 |
| Target Price | $330.67 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 2.0M | 277.0K |
| Earning Date | 11-05-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 338.81 | 25.36 |
| EPS | 8.04 | ★ 14.32 |
| Revenue | $964,271,000.00 | ★ $2,358,373,000.00 |
| Revenue This Year | $40.50 | $21.48 |
| Revenue Next Year | $22.65 | $11.90 |
| P/E Ratio | ★ $24.86 | $38.28 |
| Revenue Growth | ★ 39.86 | 13.88 |
| 52 Week Low | $166.27 | $250.05 |
| 52 Week High | $544.93 | $626.26 |
| Indicator | DUOL | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 36.48 |
| Support Level | $181.20 | $530.96 |
| Resistance Level | $194.20 | $626.26 |
| Average True Range (ATR) | 8.61 | 18.24 |
| MACD | 6.46 | -8.14 |
| Stochastic Oscillator | 93.92 | 17.60 |
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.